"The primary factors driving growth include a broad industry focus on cardiometabolic conditions, deeper penetration of multi-condition customers, strong adoption of our GLP-1 programs and more effective enrollment campaigns," said Steven Cook, Omada's chief financial officer, during the company's full-year and fourth-quarter earnings call
Jeetu Patel (Cisco): Your second biggest cost, if not your biggest cost over time, will become the cost of 2 tokens. One runs a 40-person AI-native company
What nutrients does this microscopic algae provide
For example, Ozempic is covered only to treat diabetes, and Wegovy is covered for the indication of Major Adverse Cardiovascular Events (MACE) reduction in overweight/obese adults, but neither are currently covered for obesity as a standalone condition
At Gala Health, we believe access to GLP-1 care should come with real clinical support, not just a prescription